Global Transcatheter Heart Valves Market 2018-2022

The global transcatheter heart valves market size will grow by USD 3.84 billion during 2018-2022. This report offers an analysis of the market based on the product (TMV and TAV) and end-user (hospitals, ASCs, and specialty cardiac centers). The transcatheter heart valves market research report further presents an in-depth insight on the growth prospects of the market across the Americas, APAC, and EMEA. The report analyzes the market’s competitive landscape and offers information on several companies including Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and Lepu Medical Technology.

Below are some of the key findings from the transcatheter heart valves market research report

 See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report. 

Get a FREE sample now!

Global transcatheter heart valves industry overview

The sales volume of transcatheter heart valves is increasing across several healthcare centers primarily due to the growing prevalence of various heart diseases such as cardio valvular diseases, mitral regurgitation, and aortic stenosis require valve replacement. Some of the other complications such as prosthetic valve thrombosis, mechanical hemolytic anemia, prosthetic valve endocarditis, and thromboembolism are indirectly resulting in an increased need for transcatheter heart valve replacement. Thus, the growing prevalence of mitral regurgitation and aortic stenosis will be one of the major factors that will have a positive impact on the growth of the market.

New product launches coupled with R&D activities is an emerging trend in this market space. Vendors are strategically focusing on the development and fast approvals of the new transcatheter heart valve. New product development, coupled with R&D activities, helps the vendors sustain their position within fragmented transcatheter heart valves market and to enhance their growth. Vendors are actively involved in launching innovative devices for enhancing the clinical outcomes of the transcatheter heart valves such as MRI-enabled heart valves for greater visualization. Most of the shares are occupied by the top key players, but the leadership of these vendors varies within the product segment. Owing to such factors, the global transcatheter heart valves market is expected to grow at a CAGR of over 16% during the forecast period.

Top transcatheter heart valves companies covered in this market research report

The transcatheter heart valves market is highly concentrated. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this transcatheter heart valves industry analysis report will aid clients to identify new growth opportunities and plan better business strategies.

The report offers a complete analysis of various companies including:

• Edwards Lifesciences
• Medtronic
• Boston Scientific
• Abbott
• Lepu Medical Technology

Transcatheter heart valves market segmentation based on geographic regions

• Americas
• APAC
• EMEA

With a complete study of the growth opportunities for the companies, the Americas region will account for the highest growth of this market throughout the forecast period. However, the EMEA region held the largest transcatheter heart valves market share in 2017, due to the increased heart-related disorders such as aortic stenosis and mitral regurgitation. The growing elderly population in these countries will further boost the need for transcatheter heart valves and heart valve replacement surgery in EMEA, which in turn, will have a positive impact on the transcatheter heart valves market during the projected period.

Transcatheter heart valves market segmentation based on products

• TMV
• TAV

The TAV segment will account for the highest growth in the market. In 2017, the TAV segment accounted for 70% of the global market. The demand for TAV is high as it is used as one of the standard procedures for aortic valve replacement. It is highly preferred by cardiac surgeons and performed on an affected individual whose medical condition is not feasible for conventional open-heart valve surgery. Additionally, the report also provides an accurate prediction of the contribution of the various products segments to the growth of the transcatheter heart valves market size.

Key highlights of the global transcatheter heart valves market for the forecast years 2018-2022:

• CAGR of the market during the forecast period 2018-2022
• Detailed information on factors that will accelerate the growth of the transcatheter heart valves market during the next five years
• Precise estimation of the global transcatheter heart valves market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• Growth of the transcatheter heart valves industry across the Americas, APAC, and EMEA
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive details on the factors that will challenge the growth of transcatheter heart valves companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch